📰 FDA MISSES DEADLINE FOR GRANTING FULL APPROVAL FOR NOVAVAX’S COVID-19 VACCINE, SOURCES SAY — WSJ FDA SITTING ON NOVAVAX DECISION WITH VACCINES CHIEF GONE, SOURCES SAY — WSJ FDA HAD BEEN POISED TO GRANT FULL APPROVAL TO NOVAVAX VACCINE BY APRIL 1, SOURCES SAY — WSJ